Study to Compare VMP With HDM Followed by VRD Consolidation and Lenalidomide Maintenance in Patients With Newly Diagnosed Multiple Myeloma (HO95)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01208766 |
Recruitment Status :
Active, not recruiting
First Posted : September 24, 2010
Last Update Posted : August 22, 2023
|
Sponsor:
Stichting Hemato-Oncologie voor Volwassenen Nederland
Collaborators:
Stichting European Myeloma Network
Gruppo Italiano Malattie EMatologiche dell'Adulto
DSMM (Deutsche Studiengruppe Multiples Myelom)
NMSG (Nordic Myeloma Study Group)
Central European Myeloma Study Group
Information provided by (Responsible Party):
Stichting Hemato-Oncologie voor Volwassenen Nederland
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Actual Primary Completion Date : | December 2020 |
Estimated Study Completion Date : | April 2024 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):